Showing results (1111-1120 of 2,774) with videos related to
Sort By:
Pageof 278
Bioanalysis|February 9, 2019
Direct quantitation of therapeutic antibodies for pharmacokinetic studies using immuno-purification and intact mass analysisLisa A Vasicek, Xin Zhu, Daniel S Spellman, et al.Bioanalysis|October 27, 2017
Immunoprecipitation middle-up LC-MS for in vivo drug-to-antibody ratio determination for antibody-drug conjugatesJohn A Davis, Mark Kagan, Jessica Read, et al.Bioanalysis|January 16, 2018
Pharmacokinetic determination and analysis of nortriptyline based on GC-MS coupled with hollow-fiber drop-to-drop solvent microextraction techniquePratik Kumar Jagtap, Kavita TapadiaBioanalysis|January 16, 2018
Drug monitoring by volumetric absorptive microsampling: method development considerations to mitigate hematocrit effectsKasie Fang, Chester L Bowen, John F Kellie, et al.Bioanalysis|January 19, 2018
Emerging technologies for biotherapeutic bioanalysis from a high-throughput and multiplexing perspective: insights from an AAPS emerging technology action program committeeShobha Purushothama, Mark Dysinger, Yao Chen, et al.Bioanalysis|January 19, 2018
Extended 3D and 4D cumulative plots for evaluation of unmatched incurred sample reanalysisPiotr J Rudzki, Michał Kaza, Przemysław BiecekBioanalysis|January 19, 2018
Development and validation of an ELISA to study panitumumab pharmacokineticsCéline Desvignes, Christophe Passot, David Ternant, et al.Bioanalysis|December 16, 2017
Assessing a multiplex-targeted proteomics approach for the clinical diagnosis of periodontitis using saliva samplesBrenda Mertens, Valérie Orti, Jérôme Vialaret, et al.Bioanalysis|December 16, 2017
Application of matrix-assisted laser desorption/ionization mass spectrometry imaging in combination with LC-MS in pharmacokinetic study of metforminŠtěpán Strnad, Vladimír Vrkoslav, Zuzana Klimšová, et al.Bioanalysis|May 17, 2022
2021 White Paper on Recent Issues in Bioanalysis: ISR for Biomarkers, Liquid Biopsies, Spectral Cytometry, Inhalation/Oral & Multispecific Biotherapeutics, Accuracy/LLOQ for Flow Cytometry (Part 2 - Recommendations on Biomarkers/CDx Assays Development & Validation, Cytometry Validation & Innovation, Biotherapeutics PK LBA Regulated Bioanalysis, Critical Reagents & Positive Controls Generation)Sarah Hersey, Steve Keller, Joel Mathews, et al.Pageof 278